Global Epigenomic Market Research Report 2023

Report ID: 1995848 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Epigenomic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Reagents
        1.2.3 Kits
        1.2.4 Instruments
        1.2.5 Services
    1.3 Market by Application
        1.3.1 Global Epigenomic Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Research Institution
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Epigenomic Market Perspective (2018-2029)
    2.2 Epigenomic Growth Trends by Region
        2.2.1 Global Epigenomic Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Epigenomic Historic Market Size by Region (2018-2023)
        2.2.3 Epigenomic Forecasted Market Size by Region (2024-2029)
    2.3 Epigenomic Market Dynamics
        2.3.1 Epigenomic Industry Trends
        2.3.2 Epigenomic Market Drivers
        2.3.3 Epigenomic Market Challenges
        2.3.4 Epigenomic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Epigenomic Players by Revenue
        3.1.1 Global Top Epigenomic Players by Revenue (2018-2023)
        3.1.2 Global Epigenomic Revenue Market Share by Players (2018-2023)
    3.2 Global Epigenomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Epigenomic Revenue
    3.4 Global Epigenomic Market Concentration Ratio
        3.4.1 Global Epigenomic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Epigenomic Revenue in 2022
    3.5 Epigenomic Key Players Head office and Area Served
    3.6 Key Players Epigenomic Product Solution and Service
    3.7 Date of Enter into Epigenomic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenomic Breakdown Data by Type
    4.1 Global Epigenomic Historic Market Size by Type (2018-2023)
    4.2 Global Epigenomic Forecasted Market Size by Type (2024-2029)
5 Epigenomic Breakdown Data by Application
    5.1 Global Epigenomic Historic Market Size by Application (2018-2023)
    5.2 Global Epigenomic Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Epigenomic Market Size (2018-2029)
    6.2 North America Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Epigenomic Market Size by Country (2018-2023)
    6.4 North America Epigenomic Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Epigenomic Market Size (2018-2029)
    7.2 Europe Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Epigenomic Market Size by Country (2018-2023)
    7.4 Europe Epigenomic Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Epigenomic Market Size (2018-2029)
    8.2 Asia-Pacific Epigenomic Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Epigenomic Market Size by Region (2018-2023)
    8.4 Asia-Pacific Epigenomic Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Epigenomic Market Size (2018-2029)
    9.2 Latin America Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Epigenomic Market Size by Country (2018-2023)
    9.4 Latin America Epigenomic Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Epigenomic Market Size (2018-2029)
    10.2 Middle East & Africa Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Epigenomic Market Size by Country (2018-2023)
    10.4 Middle East & Africa Epigenomic Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Roche Diagnostics
        11.1.1 Roche Diagnostics Company Detail
        11.1.2 Roche Diagnostics Business Overview
        11.1.3 Roche Diagnostics Epigenomic Introduction
        11.1.4 Roche Diagnostics Revenue in Epigenomic Business (2018-2023)
        11.1.5 Roche Diagnostics Recent Development
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Detail
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific Epigenomic Introduction
        11.2.4 Thermo Fisher Scientific Revenue in Epigenomic Business (2018-2023)
        11.2.5 Thermo Fisher Scientific Recent Development
    11.3 Eisai
        11.3.1 Eisai Company Detail
        11.3.2 Eisai Business Overview
        11.3.3 Eisai Epigenomic Introduction
        11.3.4 Eisai Revenue in Epigenomic Business (2018-2023)
        11.3.5 Eisai Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Epigenomic Introduction
        11.4.4 Novartis Revenue in Epigenomic Business (2018-2023)
        11.4.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Epigenomic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Reagents
    Table 3. Key Players of Kits
    Table 4. Key Players of Instruments
    Table 5. Key Players of Services
    Table 6. Global Epigenomic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Epigenomic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Epigenomic Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Epigenomic Market Share by Region (2018-2023)
    Table 10. Global Epigenomic Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Epigenomic Market Share by Region (2024-2029)
    Table 12. Epigenomic Market Trends
    Table 13. Epigenomic Market Drivers
    Table 14. Epigenomic Market Challenges
    Table 15. Epigenomic Market Restraints
    Table 16. Global Epigenomic Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Epigenomic Market Share by Players (2018-2023)
    Table 18. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenomic as of 2022)
    Table 19. Ranking of Global Top Epigenomic Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Epigenomic Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Epigenomic Product Solution and Service
    Table 23. Date of Enter into Epigenomic Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Epigenomic Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Epigenomic Revenue Market Share by Type (2018-2023)
    Table 27. Global Epigenomic Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Epigenomic Revenue Market Share by Type (2024-2029)
    Table 29. Global Epigenomic Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Epigenomic Revenue Market Share by Application (2018-2023)
    Table 31. Global Epigenomic Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Epigenomic Revenue Market Share by Application (2024-2029)
    Table 33. North America Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Epigenomic Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Epigenomic Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Epigenomic Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Epigenomic Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Epigenomic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Epigenomic Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Epigenomic Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Epigenomic Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Epigenomic Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Epigenomic Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Epigenomic Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Roche Diagnostics Company Detail
    Table 49. Roche Diagnostics Business Overview
    Table 50. Roche Diagnostics Epigenomic Product
    Table 51. Roche Diagnostics Revenue in Epigenomic Business (2018-2023) & (US$ Million)
    Table 52. Roche Diagnostics Recent Development
    Table 53. Thermo Fisher Scientific Company Detail
    Table 54. Thermo Fisher Scientific Business Overview
    Table 55. Thermo Fisher Scientific Epigenomic Product
    Table 56. Thermo Fisher Scientific Revenue in Epigenomic Business (2018-2023) & (US$ Million)
    Table 57. Thermo Fisher Scientific Recent Development
    Table 58. Eisai Company Detail
    Table 59. Eisai Business Overview
    Table 60. Eisai Epigenomic Product
    Table 61. Eisai Revenue in Epigenomic Business (2018-2023) & (US$ Million)
    Table 62. Eisai Recent Development
    Table 63. Novartis Company Detail
    Table 64. Novartis Business Overview
    Table 65. Novartis Epigenomic Product
    Table 66. Novartis Revenue in Epigenomic Business (2018-2023) & (US$ Million)
    Table 67. Novartis Recent Development
    Table 68. Research Programs/Design for This Report
    Table 69. Key Data Information from Secondary Sources
    Table 70. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Epigenomic Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Epigenomic Market Share by Type: 2022 VS 2029
    Figure 3. Reagents Features
    Figure 4. Kits Features
    Figure 5. Instruments Features
    Figure 6. Services Features
    Figure 7. Global Epigenomic Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Epigenomic Market Share by Application: 2022 VS 2029
    Figure 9. Research Institution Case Studies
    Figure 10. Hospital Case Studies
    Figure 11. Others Case Studies
    Figure 12. Epigenomic Report Years Considered
    Figure 13. Global Epigenomic Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Epigenomic Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Epigenomic Market Share by Region: 2022 VS 2029
    Figure 16. Global Epigenomic Market Share by Players in 2022
    Figure 17. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenomic as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Epigenomic Revenue in 2022
    Figure 19. North America Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Epigenomic Market Share by Country (2018-2029)
    Figure 21. United States Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Epigenomic Market Share by Country (2018-2029)
    Figure 25. Germany Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Epigenomic Market Share by Region (2018-2029)
    Figure 33. China Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Epigenomic Market Share by Country (2018-2029)
    Figure 41. Mexico Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Epigenomic Market Share by Country (2018-2029)
    Figure 45. Turkey Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Roche Diagnostics Revenue Growth Rate in Epigenomic Business (2018-2023)
    Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Epigenomic Business (2018-2023)
    Figure 49. Eisai Revenue Growth Rate in Epigenomic Business (2018-2023)
    Figure 50. Novartis Revenue Growth Rate in Epigenomic Business (2018-2023)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Diagnostics
Thermo Fisher Scientific
Eisai
Novartis
Frequently Asked Questions
Epigenomic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Epigenomic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Epigenomic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports